세계의 생명과학 소프트웨어 시장 보고서(2025년)
Life Science Software Global Market Report 2025
상품코드 : 1825437
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생명과학 소프트웨어 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 14.2%로 430억 9,000만 달러로 성장합니다. 예측 기간 중의 성장 배경에는 실제 증거(rwe)에 대한 중요성 증가, 사이버 보안 조치 강화, 인공지능(AI)과 머신러닝(ml)의 통합, 클라우드 기반 솔루션에 대한 수요 증가, 정밀의료에서의 역할 확대 등이 있습니다. 예측 기간의 주요 동향으로는 기술 발전의 지속, 디지털 전환의 가속화, 협업과 네트워크화, 연구개발 활동 증가, 기술 발전 등을 꼽을 수 있습니다.

향후 5년간 14.2%의 성장률 전망은 지난번 전망치보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과로 인해 이스라엘과 캐나다에서 수입되는 바이오인포매틱스 플랫폼과 AI 지원 연구 툴의 비용이 상승하고, 미국의 데이터 분석 워크플로우에 혼란을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

맞춤형 의료에 대한 수요 증가는 향후 수년간 생명과학 소프트웨어 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤형 의료는 유전학, 생활습관, 환경적 요인 등 개인의 고유한 특성에 따라 의료 의사결정과 치료를 조정하는 것입니다. 이러한 접근 방식을 지원하기 위해서는 웨어러블 기기, 유전자 검사, 전자건강기록 등 다양한 소스의 데이터를 표준화 및 통합하는 고급 소프트웨어 솔루션이 필요합니다. 생명과학 소프트웨어는 복잡한 생물학적 데이터를 분석하고 해석하는 데 중요한 역할을 하며, 연구자와 의료 전문가가 개별 환자의 치료 계획을 맞춤화할 수 있도록 돕습니다. 예를 들어 미국 비영리단체인 Personalized Medicine Coalition(PMC)이 2023년 2월에 발표한 보고서에 따르면 2021년에 새로 승인된 New Molecular Entities(NME)의 35%는 개인맞춤형 의약품이라고 강조하고 있습니다. 2022년 신규 승인되는 의약품은 12개 품목으로, 지난 8년간 지속적으로 신약 승인의 25% 이상을 차지하고 있습니다. 따라서 맞춤형 의료에 대한 수요 증가는 생명과학 소프트웨어 시장의 성장을 촉진하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Life science software encompasses specialized applications and platforms crafted to optimize and facilitate diverse processes within the life sciences sector. Widely employed across various domains in the industry, these software solutions aim to bolster research, streamline operations, and enhance overall efficiency.

Life science software can be categorized into three main types, predictive, descriptive, and prescriptive. Predictive software employs predictive analytics and can be deployed either on-premise or hosted. Its applications span across diverse areas such as marketing, compliance, research and development (R&D), pharmacovigilance, and supply chain management (SCM). This type of software finds utility in various end-user sectors, including healthcare institutes, the biopharmaceutical industry, the medical devices industry, and medical research centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The life science software market research report is one of a series of new reports from The Business Research Company that provides life science software market statistics, including life science software industry global market size, regional shares, competitors with life science software market share, detailed life science software market segments, market trends, and opportunities, and any further data you may need to thrive in the life science software industry. This life science software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The life science software market size has grown rapidly in recent years. It will grow from $22.31 billion in 2024 to $25.35 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to regulatory compliance requirements, data integration and management needs, rising demand for personalized medicine, globalization of clinical trials, patient-centric approaches.

The life science software market size is expected to see rapid growth in the next few years. It will grow to $43.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increased emphasis on real-world evidence (rwe), enhanced cybersecurity measures, integration of artificial intelligence (AI) and machine learning (ml), growing demand for cloud-based solutions, expanded role in precision medicine. Major trends in the forecast period include continued technological advancements, accelerated digital transformation, collaboration and networking, increasing research and development activities, advancements in technology.

The forecast of 14.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. data analysis workflows by increasing costs for bioinformatics platforms and AI-assisted research tools imported from Israel and Canada, potentially compromising research efficiency and increasing computational biology budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for personalized medicine is expected to drive the expansion of the life science software market in the coming years. Personalized medicine involves tailoring healthcare decisions and treatments based on an individual's unique characteristics, such as genetics, lifestyle, and environmental factors. To support this approach, advanced software solutions are necessary to standardize and integrate data from various sources, including wearable devices, genetic tests, and electronic health records. Life science software plays a critical role in analyzing and interpreting complex biological data, helping researchers and healthcare professionals customize treatment plans for individual patients. For example, a February 2023 report from the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit, highlighted that personalized medicines accounted for 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently represented at least 25% of new drug approvals over the past eight years, a substantial increase from under 10% a decade ago. Therefore, the rising demand for personalized medicine is fueling the growth of the life science software market.

Prominent companies in the life science software market are incorporating advanced technologies, such as generative AI, machine learning (ML), and computer-aided drug design (CADD), to enhance the drug discovery process, improve efficiency, and expedite breakthroughs. Generative AI is utilized for designing novel molecular structures, while ML algorithms analyze extensive datasets to identify potential drug candidates and predict their efficacy. Integrated with CADD tools, these technologies enable researchers to computationally simulate and optimize drug interactions, significantly expediting the identification and development of promising compounds. In December 2023, Merck, a Germany-based science and technology company, introduced AIDDISON, a drug discovery software leveraging artificial intelligence (AI) and machine learning (ML) technologies. AIDDISON aims to accelerate the identification of novel medications and enhance the efficiency of the drug development process by evaluating massive volumes of data to identify prospective medication candidates more rapidly and effectively than traditional approaches.

In August 2024, Valsoft Corporation Inc., a Canada-based company specializing in acquiring and developing vertical market software businesses, acquired Anju Software for an undisclosed amount. This acquisition is aimed at strengthening Valsoft's position in the life sciences sector and expanding its portfolio with flexible solutions for clinical research, medical affairs, and data science. Anju Software, a U.S.-based company, is known for designing and developing software platforms tailored for the life sciences industry.

Major companies operating in the life science software market report are Meta Platforms Inc., Optum Inc., International Business Machines Corp., Deloitte, Thermo Fisher Scientific Inc., Oracle, SAP, Fujitsu Ltd., Cognizant, DXC Technology Co, HCL Technologies Ltd., Dassault Systemes, EPIC Systems Corporation, SAS Institute Inc., INFOR, PAREXEL International Corporation, MEDICAL Information Technology Inc., Veeva Systems Inc., TIBCO Software Inc., PTC Therapeutics Inc., Cegedim SA, CPSI, Model N Inc., Medidata Solution Inc., ArisGlobal LLC, Perceptive Informatics Inc., Elinext, Signiant Inc., Allscripts Healthcare LLC, Jag products LLC

North America was the largest region in the life science software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the life science software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The life science software market includes revenues earned by entities by providing services such as genomic analysis services, clinical trial management services, laboratory information management system (LIMS) services, bioinformatics and computational biology services, drug discovery and development services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The Life Science Software market consists of sales of laboratory information management systems, electronic lab notebooks, scientific data analysis and visualization software, and scientific modeling and simulation software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Life Science Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on life science software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for life science software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The life science software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Life Science Software Market Characteristics

3. Life Science Software Market Trends And Strategies

4. Life Science Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Life Science Software Growth Analysis And Strategic Analysis Framework

6. Life Science Software Market Segmentation

7. Life Science Software Market Regional And Country Analysis

8. Asia-Pacific Life Science Software Market

9. China Life Science Software Market

10. India Life Science Software Market

11. Japan Life Science Software Market

12. Australia Life Science Software Market

13. Indonesia Life Science Software Market

14. South Korea Life Science Software Market

15. Western Europe Life Science Software Market

16. UK Life Science Software Market

17. Germany Life Science Software Market

18. France Life Science Software Market

19. Italy Life Science Software Market

20. Spain Life Science Software Market

21. Eastern Europe Life Science Software Market

22. Russia Life Science Software Market

23. North America Life Science Software Market

24. USA Life Science Software Market

25. Canada Life Science Software Market

26. South America Life Science Software Market

27. Brazil Life Science Software Market

28. Middle East Life Science Software Market

29. Africa Life Science Software Market

30. Life Science Software Market Competitive Landscape And Company Profiles

31. Life Science Software Market Other Major And Innovative Companies

32. Global Life Science Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Life Science Software Market

34. Recent Developments In The Life Science Software Market

35. Life Science Software Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기